InvestorsHub Logo
Followers 95
Posts 3767
Boards Moderated 0
Alias Born 06/14/2012

Re: noreen post# 2883

Wednesday, 05/31/2017 2:49:03 PM

Wednesday, May 31, 2017 2:49:03 PM

Post# of 18220
All good. I'm with you dwarren - the contracts are already established (imo). I think they are just waiting to make sure everything is in place and first sales are done before they officially PR anything about contracts. A smart company would do that.

In looking back through some of the PRs and news from sites - it's clear that IMUN is already setup and rolling with Fidson Healthcare. I like this:

Nigerian drugmaker Fidson Healthcare has entered into a partnership with US firms, Immune Therapeutics, GB Pharma and American Hospitals & Resort (AHAR) for the marketing and distribution of a new product, Lodonal (naltrexone hydrochloride), a patent-protected product that is indicated for the management of patients with immune-compromising diseases.

The partnership will leverage Fidson’s strong and experienced marketing base, robust distribution channels and efficient customer and technical support services to promote Lodonal in Nigeria. The distribution will become effective, upon completion of the ongoing NAFDAC (the National Agency for Food and Drug Administration and Control) approved 90-day bridging trial evaluating the efficacy and safety of the product. Fidelis Ayebae, managing director of the Nigerian company, said: “Fidson is truly excited about this collaboration with Immune Therapeutics and GB Pharma/AHAR. We know that success in this industry going into the future will be dependent on having the right partnerships, and we could not have asked for better partners at this stage of our growth.” This partnership is another strategic approach by the management of Fidson Healthcare to further strengthen the company’s growth.


http://venturesafrica.com/story/nigerias-fidson-partners-with-us-firms-for-lodonal/

And Fidson's new manufacturing facility is awesome! I'm thinking they built it with IMUN in mind, you think?

Dr Ayebae said the present position of the country’s pharmaceutical manufacturing business requires such transformational investment as the new Fidson plant, to meet future healthcare demands of Nigerians. He noted that with the completion of the plant, Nigerian pharma industry stands a chance of being launched into global reckoning and attract foreign investors.

Dr Ayebae highlighted the several benefits of the factory to include high quality and affordable healthcare products, world-class pharmaceutical manufacturing capacity, employment generation, increased local content, generation of stronger partnerships, as well as strategic brand and market positioning.

He said the plant would manufacture large scale pharmaceutical products that would take care of the healthcare needs of Nigerians, thereby further strengthening the company’s leadership position in the Nigerian pharmaceutical industry and also place the company on the global pharmaceutical reckoning.


http://www.fidson.com/new-press-release/health-minister-lauds-fidson-on-new-factory-reaffirms-support-for-local-manufacturing

And another interesting articles about Fidson:
https://www.pmnewsnigeria.com/2016/01/29/fidson-gb-pharma-holdings-plan-expansion-in-nigeria/

Plus - remembering how much Lodonal has been preached to the African countries:
http://thewestsidegazette.com/gb-pharma-holdings-strategically-positions-itself-in-africa-for-distribution-and-contribution-to-reducing-hivaids-with-wonder-drug-lodonaltm/

This stuff takes time folks - well real business does. Not fluff PR's and fake news like most OTC companies. It's all coming together and I get that everyone is antsy. Just check multiple websites and sources and you will see the same thing...IMUN is going to be doing well very soon.

And most of my articles are focused on JUST Nigeria - not even all the other countries that will be coming up to speed ASAP now that Nigeria has signed off. The good stuff is coming...

"One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute." - William Feather.